SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-22-007082
Filing Date
2022-10-05
Accepted
2022-10-05 17:40:23
Documents
1
Period of Report
2022-10-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 5796
  Complete submission text file 0001562180-22-007082.txt   7480
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Reporting) CIK: 0001689813 (see all company filings)

State of Incorp.: D8 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-41477 | Film No.: 221296616
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Ltd. (Issuer) CIK: 0001935979 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences